文献速递前列腺癌

磁共振成像检测前列腺癌骨转移的诊断效能:系统综述与Meta分析

Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol · 2017-04-12

该系统综述与Meta分析检索MEDLINE和EMBASE至2017年1月22日,纳入10项研究共1031例前列腺癌患者,评估≥1.5 T磁共振成像检测骨转移的诊断效能。合并敏感度为0.96(95%CI 0.87-0.99),特异度为0.98(95%CI 0.93-0.99);使用两个或以上成像平面的研究敏感度最高(0.99 [95%CI 0.98-1.00])。作者结论为当代MRI敏感度和特异度均优异,但纳入研究间存在异质性,应用结果需谨慎。

要点

  • 当代(≥1.5 T)MRI检测前列腺癌骨转移的合并敏感度为0.96(95%CI 0.87-0.99),特异度为0.98(95%CI 0.93-0.99)。
  • Meta回归分析中仅成像平面数量(≥2 vs 1)是影响异质性的显著因素(p<0.01)。
  • 使用两个或以上成像平面的研究(n=4)敏感度最高,为0.99(95%CI 0.98-1.00)。

核心结论

  • 当代MRI对前列腺癌患者骨转移的检测显示出优异的敏感度和特异度。
  • 使用两个或以上成像平面可能进一步提高敏感度。
  • 由于纳入研究间存在异质性,应用本研究结果时需谨慎。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和EMBASE至2017年1月22日。
  • 纳入使用≥1.5 T扫描仪检测前列腺癌患者骨转移的研究,参考标准为组织病理学或最佳价值比较。
  • 共纳入10项研究、1031例患者,由两名独立评价者使用QUADAS-2工具评估方法学质量。
  • 计算纳入研究的患者水平敏感度和特异度,合并并绘制分层 summary receiver operating characteristic 图,进行Meta回归和敏感度分析。

主要发现

  • 合并敏感度为0.96(95%CI 0.87-0.99),合并特异度为0.98(95%CI 0.93-0.99)。
  • Meta回归分析中,仅成像平面数量(≥2 vs 1)是影响异质性的显著因素(p<0.01)。
  • 敏感度分析显示各亚组特异度估计值相当且持续较高,但敏感度估计值存在一定差异。
  • 使用两个或以上成像平面的研究(n=4)敏感度最高,为0.99(95%CI 0.98-1.00)。

关键数值与推荐

  • 纳入标准:使用≥1.5 T扫描仪的MRI检测前列腺癌患者骨转移,参考标准为组织病理学或最佳价值比较。
  • 合并敏感度0.96(95%CI 0.87-0.99),合并特异度0.98(95%CI 0.93-0.99)。
  • 使用两个或以上成像平面的研究(n=4)敏感度为0.99(95%CI 0.98-1.00)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究间存在异质性,应用本研究结果时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Magnetic resonance imaging (MRI) has been tested for detecting bone metastasis and has shown promising results. Yet, consensus has not been reached regarding whether it can replace the role of bone scintigraphy in this clinical setting or not. OBJECTIVE: To review the diagnostic performance of contemporary (≥1.5 T) MRI for the detection of bone metastasis in patients with prostate cancer. EVIDENCE ACQUISITION: MEDLINE and EMBASE were searched up to January 22, 2017. We included studies that used MRI using ≥1.5-T scanners for the detection of bone metastasis in patients with prostate cancer, using histopathology or best value comparator as the reference standard. Two independent reviewers assessed the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Per-patient sensitivity and specificity of included studies were calculated, and pooled and plotted in a hierarchical summary receiver operating characteristic plot. Meta-regression and sensitivity analyses were performed. EVIDENCE SYNTHESIS: Ten studies (1031 patients) were included. Pooled sensitivity was 0.96 (95% confidence interval [CI] 0.87-0.99) with a specificity of 0.98 (95% CI 0.93-0.99). At meta-regression analysis, only the number of imaging planes (≥2 vs 1) was a significant factor affecting heterogeneity (p<0.01). Sensitivity analyses showed that specificity estimates were comparable and consistently high across all subgroups, but sensitivity estimates demonstrated some differences. Studies using two or more planes (n=4) had the highest sensitivity (0.99 [95% CI 0.98-1.00]). CONCLUSIONS: Contemporary MRI shows excellent sensitivity and specificity for detection of bone metastasis in patients with prostate cancer. Using two or more imaging planes may further improve sensitivity. However, caution is needed in applying our results due to the heterogeneity among the included studies. PATIENT SUMMARY: We reviewed studies using contemporary magnetic resonance imaging (MRI) for the detection of bone metastasis in prostate cancer patients. MRI shows excellent diagnostic performance in finding patients with bone metastasis.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Woo S, Suh CH, Kim SY, et al. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2017. PMID: 28412063. doi:10.1016/j.eururo.2017.03.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。